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The pregnane X receptor belongs to the superfamily of nuclear receptors; it is a ligand 
dependent transcription factor regulating expression of its target genes. During last two decades, 
PXR was extensively studied as a xenosensor, i.e. the receptor, which is able to bind xenobiotics 
including many drugs and to regulate their metabolism by induction of the most important 
metabolizing enzymes of both phase I. and phase II. Induction, i.e. transcriptional stimulation 
of expression of the most important cytochrome P450 enzymes, by PXR ligands was described 
in details at many levels. 
Within this dissertation thesis, I am dealing with aspects of regulation via PXR, which 
extend the common understanding of PXR as a receptor whose exclusive function is to 
up-regulate drug metabolizing enzymes mediated by its agonists. 
Within the first, project I studied regulation of OCT1 transporter in hepatic cell models, I 
shown that PXR did not induce, but it rather suppressed the expression of this important 
transporter of drugs and endogenous substances. This work is the first detailed study presenting 
mechanism of down-regulation of drug transporter via PXR. 
Within the second work, I studied resveratrol and structurally related stilbenoid substances 
to regulate expression of PXR target genes. Resveratrol was described as one of the PXR 
inhibitors, however studies published on this issue were contradictory in their findings. 
Within the third research field, I participated on the study of interaction of endogenous bile 
acids and their hypothetical metabolites with PXR. The aim of the study was to elucidate if 
metabolites of bile acids can act as endogenous ligands of PXR. 
Overall, my work extended our general understanding of PXR from the perspective of 
down-regulation of OCT1 or the potential inhibition of PXR by substances structurally related 
to resveratrol. 
 
